Who We Are

Oyster Venture Partners consists of a multi-disciplinary team of highly experienced operational deal makers who have worked across the biotechnology, therapeutic, diagnostic, medical technology, digital healthcare and healthcare
sectors around the globe. Our culture centres on closely partnering our client base, throughout the capital raising process supporting all levels of experienced leaders with a wide range of funding and corporate transactions.

The Team

Rupert Lewis
CEO

David D’Alton
Chairman

Kaarel Aulik
Analyst

LinkedIn

20+ years corporate transaction experience across the globe, with a driving passion for supporting innovation in healthcare. Lead sponsor of Oyster’s unique platform solution to accelerate the capital raising process

LinkedIn

30+ years international business development and capital raising experience across the life science spectrum. Lead Partner with the UK Government’s Department of International Trade (DIT) Life Sciences Organisation (LSO)

LinkedIn

10+ years experience within the healthcare sector, supporting strategic decision making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.

Dr Gilles Devillers
Venture Advisor

Dr Kris Motmans, PhD
Venture Partner

Carl Weir
Venture Partner

LinkedIn

Serial Entrepreneur in the
pharmaceutical and biotech
industry. A scientific, engineering
and business background in
negotiation, strategic marketing,
drug delivery, pharma and
biotechnology.

LinkedIn

Serial advisor within the life science sector, covering both public and private transactions, covering investment sourcing and completion.

LinkedIn

Serial advisor and innovator with a track record of business & digital transformation, product strategy and advisory across finance, legal, AI, ML, Big Data, blockchain, payments, and digital healthcare.

To be appointed
Chief Technology Officer

Experienced CTO in healthtech with a background of delivering technology infrastructure across the sector.

Rupert Lewis
CEO

M: +44 (0)7860 640444
E: rupert.lewis@oystervp.com

LinkedIn

20+ years corporate transaction experience across the globe, with a driving passion for supporting innovation in healthcare. Lead sponsor of Oyster’s unique platform solution to accelerate the capital raising process.

David D’Alton
Chairman

M: +44 (0)7836 224422
E: david.dalton@oystervp.com
LinkedIn
30+ years international business development and capital raising experience across the life science spectrum. Lead Partner with the UK Government’s Department of International Trade (DIT) Life Sciences Organisation (LSO)

Kaarel Aulik
Analyst

M: +44 (0)749 684 7155
E: kaarel.aulik@oystervp.com

LinkedIn

10+ years experience within the healthcare sector, supporting strategic decision making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.

Dr Gilles Devillers
Venture Advisor

LinkedIn

Serial Entrepreneur in the
pharmaceutical and biotech
industry. A scientific, engineering
and business background in
negotiation, strategic marketing,
drug delivery, pharma and
biotechnology.

To be appointed
Chief Technology Officer

Experienced CTO in healthtech with a background of delivering technology infrastructure across the sector.

Dr Kris Motmans, PhD
Venture Partner and Chief Scientific Investment Officer

LinkedIn

Serial advisor within the life science sector, covering both public and private transactions, covering investment sourcing and completion.